DYNAMICS OF ECHOCARDIOGRAPHIC PARAMETERS OF PULMONARY  HYPERTENSION DURING BOSENTAN THERAPY IN PATIENTS UNDERGOING  PROGRAM HEMODIALYSIS

dc.contributor.author	DAMINOV Botir., ABDUVAKHITOVA Asal
dc.date.accessioned	2026-09-05T12:05:16Z
dc.date.available	2026-09-05T12:05:16Z
dc.date.issued	2025-11-06
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5098
dc.description.abstract	Associated pulmonary hypertension worsens the prognosis for patients undergoing scheduled hemodialysis. Endothelin receptor antagonists, including bosentan, are standard treatment for pulmonary arterial hypertension. Echocardiography (TTE) remains a key tool for screening and longitudinal monitoring of the right heart and estimating PH probability. In this cohort, the addition of bosentan to comprehensive therapy in maintenance hemodialysis patients with pulmonary hypertension was associated with a marked improvement in pulmonary hemodynamics and right heart function, demonstrating clinical feasibility in carefully selected hemodialysis patients with regular safety monitoring.	en_US
dc.language.iso	en_US	en_US
dc.publisher	O'zbekiston (БИОМЕДИЦИНА ВА АМАЛИЁТ ЖУРНАЛИ) N6	en_US
dc.relation.ispartofseries	UDC;616.131-073.75:615.33:616.61-085.38
dc.subject	pulmonary hypertension; chronic kidney disease; hemodialysis; bosentan; echocardiography; TAPSE; sPAP; endothelin-1.	en_US
dc.title	DYNAMICS OF ECHOCARDIOGRAPHIC PARAMETERS OF PULMONARY HYPERTENSION DURING BOSENTAN THERAPY IN PATIENTS UNDERGOING PROGRAM HEMODIALYSIS	en_US
dc.type	Article	en_US